Close Menu

NEW YORK (GenomeWeb) – Bio-Techne said today that its fiscal 2018 fourth quarter revenues were up 15 percent over Q4 2017. On an organic basis, revenues grew 9 percent year over year. 

For the three months ended June 30, the firm reported revenues of $180.3 million compared to $156.6 million in Q4 2017, besting analysts' average estimate of $174.8 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.